Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

CSMD3 loss drives aggressive behavior and tumor consolidation in oral squamous premalignant cells

ABSTRACT: Oral squamous cell carcinoma (OSCC) remains a significant global health burden. Genomic data identify Csmd3 as the third most frequently mutated gene in HNSCC (29% of cases) correlating with poor clinical outcome and prognosis. Despite this, the functional role of CSMD3 in oral premalignancy and malignant transformation remains largely unexplored. In this study, we utilized CRISPR-Cas9 system to inactivate CSMD3 in an oral premalignant cell line and characterize knockout in in vitro oral premalignant cell line and in vivo orthotopic model. Functional assays demonstrate that CSMD3 loss significantly enhances cell survival (P < 0.001), while decreasing migration (P = 0.005). Transcriptomic profiling and Gene Set Enrichment Analysis (GSEA) revealed multi-faceted reprogramming characterized by enriched expression of oncogenic survival and stress signaling genes, metabolic rewiring, inflammatory mediators, and structural remodeling driven by altered expression of contraction, actin cross-linking proteins, and polymerization genes. Orthotopic modeling further revealed that CSMD3 loss resulted in significantly increased tumor area fraction (P < 0.0001) and intratumoral cellular density (P < 0.0001). Our study emphasizes the role of CSMD3 loss in promoting aggressive behavior of oral premalignancy, which has a potential for risk stratification, a novel prognostic or diagnostic biomarker, and a target for therapeutic intervention.

ORGANISM(S): Mus musculus

PROVIDER: GSE342871 | GEO | 2026/08/06

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

miRNA expression in PTEN-deficient premalignant DP thymocytes

Project description:T cell-specific deletion of PTEN induces premalignancy in CD4+ CD8+ (DP) immature T cells in the thymus, which progresses to the development of mature CD4+ T cell lymphomas in the lymph nodes and spleen. As part of a screen to identify factors that inhibit progression to malignancy, we compared miRNA expression in premalignant PTEN-deficient DP thymocytes versus wild-type controls. DP thymocytes were collected by cell sorting from three 9-week-old, premalignant T cell-specific PTEN-deficient mice (tPTEN-/-) and three littermate controls. miRNA expression was assessed relative to a reference pool generated from an equal mixture of all samples.

2014-04-12 | E-GEOD-56759 | biostudies-arrayexpress

CSMD3 loss drives aggressive behavior and tumor consolidation in oral squamous premalignant cells

Project description:CSMD3 loss drives aggressive behavior and tumor consolidation in oral squamous premalignant cells

| PRJNA1508999 | ENA

miRNA expression in PTEN-deficient premalignant DP thymocytes

2014-04-12 | GSE56759 | GEO

Bioadhesive black rasberry gel effect on gene expression and proinflammatory proteins in human premalignant oral lesions

Project description:This portion of the study evaluated the effects of topical 10% black raspberry gel application on gene expression profiles of premalignant oral lesions. Topical application of the bioadhesive black rasberry gel was observed to modulate gene expression and reduce proinflammatory proteins in human premalignant oral lesions. Keywords: Human oral tissues treated with 10% berry gfel

2008-06-01 | GSE10174 | GEO

Genotyping of human premalignant oral keratinocyte line SVpgC2a loss of heterozygosity (LOH) during FOXM1B-induced malignant transformation

Project description:Genome-wide SNP profilling for loss of heterozygosity (LOH) during FOXM1B-induced malignant transformation in a human premalignant oral keratinocyte line SVpgC2a. Experiment Overall Design: Eight FOXM1B-induced malignant clones (SVFN1-8) that grew in soft agar were grown as individual cell lines and gDNA harvested from each clone for SNP array analysis compared to wild-type non-transformed SVpgC2a as control to obtain loss of heterozygosity profiles.

2009-06-23 | E-GEOD-11782 | biostudies-arrayexpress

Profiling long non-coding RNA expression in oral premalignant lesions.

Project description:Oral epithelial dysplasias are believed to progress through a series of histopathological stages; from mild to severe dysplasia, to carcinoma in situ, and finally to invasive OSCC. Underlying this change in histopathological grade are gross chromosome alterations and changes in gene expression of both protein-coding genes and non-coding RNAs. Recent papers have described associations of aberrant expression of microRNAs, one class of non-coding RNAs, with oral cancer. However, expression profiling of long non-coding RNAs (lncRNAs) has not been reported. Long non-coding RNAs are a novel class of mRNA-like transcripts with no protein coding capacity, but with a variety of functions including roles in epigenetics and gene regulation. In recent reports, the aberrant expression of lncRNAs has been associated with human cancers, suggesting a critical role in tumorigenesis. Here, we present the first long non-coding RNA expression map for the human oral mucosa. We describe the expression of 325 long non-coding RNAs, suggesting lncRNA expression contributes significantly to the oral transcriptome. Intriguingly, 60% of the detected lncRNAs show aberrant expression in oral premalignant lesions. A number of these lncRNAs have been previously associated with other human cancers. A total of six normal oral samples and ten oral premalignant lesions were used to construct SAGE libraries which were then queried for long non-coding RNA expression profiles. The six normal oral samples were previously deposited as GSE8127.

2011-08-14 | E-GEOD-31021 | biostudies-arrayexpress

Microarray expression profiling data for premalignant mammary epithelial cells with a K8+ luminal origin

Project description:This dataset contains gene expression profiles of premalignant mammary epithelial cells (MEC) with loss of either p53 alone, or loss of both p53 and RUNX1, or loss of both p53 and BRCA1. The premalignant MECs were generated in female mice carrying their corresponding conditional knockout alleles as well as a conditional YFP-reporter, upon intraductal injection of Cre-expressing adenovirus under the control of the Keratin 8 (K8) promoter (Ad-K8-Cre) to their mammary glands.

2026-04-06 | GSE316272 | GEO

Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis

Project description:Lung squamous cell carcinoma (SCC) is thought to arise from premalignant lesions in the airway epithelium, therefore studying these lesions is critical for understanding lung carcinogenesis. We performed RNA sequencing on laser-microdissected representative cell populations along the SCC pathological continuum of patient-matched normal basal cells, premalignant lesions, and tumor cells. We discovered transcriptomic changes and identified genomic pathways altered with initiation and progression of SCC within individual patients. We used immunofluorescent staining to confirm gene expression changes in premalignant lesions and tumor cells, including increased expression of SLC2A1, CEACAM5, and PTBP3 at the protein level and increased activation of MYC via nuclear translocation. Cytoband enrichment analysis revealed coordinated loss and gain of expression in chromosome 3p and 3q regions, respectively, during carcinogenesis. This is the first gene expression profiling of airway premalignant lesions with patient-matched samples that provides insight into the mechanisms of stepwise lung carcinogenesis. Profiling of mRNA expression in laser-microdissected normal airway basal cells, premalignant airway lesions, and lung SCC tumor cells by massively parallel RNA sequencing.

2014-07-03 | E-GEOD-49155 | biostudies-arrayexpress

Profiling long non-coding RNA expression in oral premalignant lesions.

2011-08-15 | GSE31021 | GEO

Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion

Project description:Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion

| PRJNA731941 | ENA